Oral Berotralstat Expanded Access Program

NCT04428632 · clinicaltrials.gov ↗

APPROVED_FOR_MARKETING

Status

INDUSTRY

Sponsor class

Conditions

Hereditary Angioedema
HAE
Prophylaxis

Interventions

DRUG: Berotralstat

Sponsor

BioCryst Pharmaceuticals